Joel Morris

2.0k total citations · 1 hit paper
19 papers, 1.5k citations indexed

About

Joel Morris is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Joel Morris has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 5 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in Joel Morris's work include Asthma and respiratory diseases (5 papers), Synthesis of Organic Compounds (3 papers) and HIV/AIDS drug development and treatment (3 papers). Joel Morris is often cited by papers focused on Asthma and respiratory diseases (5 papers), Synthesis of Organic Compounds (3 papers) and HIV/AIDS drug development and treatment (3 papers). Joel Morris collaborates with scholars based in United States and Sweden. Joel Morris's co-authors include Daniel C. Feldman, Donn G. Wishka, Steven L. Bender, David A. Evans, Charles N. Serhan, Bengt Samuelsson, Magnus Ingelman‐Sundberg, Jesper Z. Haeggström, Anders Hansson and Mats Hámberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Academy of Management Review.

In The Last Decade

Joel Morris

19 papers receiving 1.4k citations

Hit Papers

The Dimensions, Antecedents, and Consequences of Emotiona... 1996 2026 2006 2016 1996 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel Morris United States 16 448 392 321 268 190 19 1.5k
Michael D. Thompson United States 31 101 0.2× 134 0.3× 1.3k 4.0× 51 0.2× 104 0.5× 84 2.9k
Stephen Mills United Kingdom 27 549 1.2× 185 0.5× 373 1.2× 18 0.1× 189 1.0× 97 2.0k
John Williams United States 22 129 0.3× 48 0.1× 347 1.1× 125 0.5× 40 0.2× 144 1.9k
Christopher W. Boyce United States 15 134 0.3× 830 2.1× 393 1.2× 28 0.1× 39 0.2× 26 1.7k
James E. Macdonald United States 15 145 0.3× 120 0.3× 287 0.9× 29 0.1× 29 0.2× 28 1.1k
Susan Young United States 25 245 0.5× 44 0.1× 680 2.1× 23 0.1× 156 0.8× 91 2.1k
Hiroko Nishida Japan 20 76 0.2× 134 0.3× 495 1.5× 37 0.1× 124 0.7× 65 1.3k
Minmin Wang China 18 88 0.2× 105 0.3× 361 1.1× 107 0.4× 71 0.4× 85 1.1k
John C. Phillips United Kingdom 23 247 0.6× 59 0.2× 477 1.5× 11 0.0× 108 0.6× 119 2.2k
Peter Dwyer United Kingdom 25 794 1.8× 73 0.2× 366 1.1× 13 0.0× 31 0.2× 63 2.8k

Countries citing papers authored by Joel Morris

Since Specialization
Citations

This map shows the geographic impact of Joel Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Morris more than expected).

Fields of papers citing papers by Joel Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Morris. The network helps show where Joel Morris may publish in the future.

Co-authorship network of co-authors of Joel Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Morris. A scholar is included among the top collaborators of Joel Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Morris. Joel Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wishka, Donn G., David R. Graber, Eric P. Seest, et al.. (1998). Stereoselective Synthesis of Furo[2,3-c]pyridine Pyrimidine Thioethers, A New Class of Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors. The Journal of Organic Chemistry. 63(22). 7851–7859. 56 indexed citations
2.
Nugent, Richard A., Stephen T. Schlachter, Michael J. Murphy, et al.. (1998). Pyrimidine Thioethers:  A Novel Class of HIV-1 Reverse Transcriptase Inhibitors with Activity Against BHAP-Resistant HIV. Journal of Medicinal Chemistry. 41(20). 3793–3803. 56 indexed citations
4.
Morris, Joel & Daniel C. Feldman. (1996). The Dimensions, Antecedents, and Consequences of Emotional Labor. Academy of Management Review. 21(4). 986–986. 606 indexed citations breakdown →
5.
Romero, Donna L., Robert A. Olmsted, Toni J. Poel, et al.. (1996). Targeting Delavirdine/Atevirdine Resistant HIV-1:  Identification of (Alkylamino)piperidine-Containing Bis(heteroaryl)piperazines as Broad Spectrum HIV-1 Reverse Transcriptase Inhibitors. Journal of Medicinal Chemistry. 39(19). 3769–3789. 50 indexed citations
6.
Morris, Joel, Donn G. Wishka, Alice H. Lin, et al.. (1993). Synthesis and biological evaluation of antiplatelet 2-aminochromones. Journal of Medicinal Chemistry. 36(14). 2026–2032. 32 indexed citations
7.
Richards, I M, Frank F. Sun, Bruce Taylor, et al.. (1991). Contribution of Leukotriene B4 to Airway Inflammation and the Effect of Antagonists. Annals of the New York Academy of Sciences. 629(1). 274–287. 27 indexed citations
9.
Richards, I M, Robert L. Griffin, Jo A. Oostveen, et al.. (1989). Effect of the Selective Leukotriene B 4 Antagonist U-75302 on Antigen-induced Bronchopulmonary Eosinophilia in Sensitized Guinea Pigs. American Review of Respiratory Disease. 140(6). 1712–1716. 47 indexed citations
10.
Morris, Joel, et al.. (1989). Inhibition of in vitro guinea pig eosinophil chemotaxis by leukotriene B4 antagonist U-75,302.. PubMed. 19. 195–8. 6 indexed citations
11.
Evans, David A., Steven L. Bender, & Joel Morris. (1988). The total synthesis of the polyether antibiotic X-206. Journal of the American Chemical Society. 110(8). 2506–2526. 183 indexed citations
12.
Lin, Alice H., Joel Morris, Donn G. Wishka, & Robert R. Gorman. (1988). Novel Molecules That Antagonize Leukotriene B4 Binding to Neutrophils. Annals of the New York Academy of Sciences. 524(1). 196–200. 21 indexed citations
13.
Morris, Joel & Donn G. Wishka. (1988). Synthesis of novel antagonists of leukotriene B4. Tetrahedron Letters. 29(2). 143–146. 30 indexed citations
14.
Morris, Joel & Donn G. Wishka. (1986). Synthesis of lipoxin b. Tetrahedron Letters. 27(7). 803–806. 34 indexed citations
15.
Serhan, Charles N., Mats Hámberg, Bengt Samuelsson, Joel Morris, & Donn G. Wishka. (1986). On the stereochemistry and biosynthesis of lipoxin B.. Proceedings of the National Academy of Sciences. 83(7). 1983–1987. 81 indexed citations
16.
Hansson, Anders, Charles N. Serhan, Jesper Z. Haeggström, et al.. (1986). Activation of protein kinase C by lipoxin A and other eicosanoids. Intracellular action of oxygenation products of arachidonic acid. Biochemical and Biophysical Research Communications. 134(3). 1215–1222. 192 indexed citations
17.
Morris, Joel & Donn G. Wishka. (1986). Synthesis of lipoxin B.. PubMed. 16. 99–109. 1 indexed citations
18.
Morris, Joel & C.J. Thorns. (1985). Evidence for the reaction of bovine autoantibodies with Mycobacterium bovis. Veterinary Record. 117(8). 169–169. 4 indexed citations
19.
Morris, Joel, C.J. Thorns, & Jane A. Woolley. (1985). The Identification of Antigenic Determinants on Mycobacterium bovis Using Monoclonal Antibodies. Microbiology. 131(7). 1825–1831. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026